Back

Stromal signals dominate gene expression signature scores that aim to describe cancer-intrinsic stemness or mesenchymality characteristics

Kreis, J.; Aybey, B.; Geist, F.; Brors, B.; Staub, E.

2023-08-27 bioinformatics
10.1101/2023.08.25.554747 bioRxiv
Show abstract

PurposeEpithelial-to-mesenchymal transition (EMT) in cancer cells confers migratory ability, a crucial aspect of tumor metastasis that frequently leads to death. In multiple studies, authors proposed gene expression signatures for EMT, stemness, and mesenchymality (EMT-related) characteristics of tumors based on bulk tumor expression profiling. However, recent studies have suggested that non-cancerous cells in the tumor micro- or macroenvironment heavily influence individual signature profiles. Experimental DesignWe analyzed scores of 11 published and frequently referenced gene expression signatures in bulk, single cell, and pseudo bulk expression data across multiple cancer types. ResultsOur study strengthens and extends the influence of non-cancerous cells on signatures that were proposed to describe EMT-related (EMT, mesenchymal, or stemness) characteristics in various cancer types. The cell type composition, especially the amount of tumor cells, of a tumor sample frequently dominates EMT-related signature scores. Additionally, our analyses revealed that stromal cells, most often fibroblasts, are the main drivers of the EMT-related signature scores. ConclusionsWe call attention to the risk of false conclusions about tumor properties when interpreting EMT-related signatures, especially in a clinical setting: high patient scores of EMT-related signatures or calls of "stemness subtypes" often result from low tumor cell content in tumor biopsies rather than cancer cell-specific stemness or mesenchymality/EMT characteristics.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
International Journal of Cancer
42 papers in training set
Top 0.1%
19.1%
2
Cancers
200 papers in training set
Top 0.2%
13.0%
3
PLOS ONE
4510 papers in training set
Top 17%
10.7%
4
Scientific Reports
3102 papers in training set
Top 5%
10.3%
50% of probability mass above
5
PeerJ
261 papers in training set
Top 0.4%
7.0%
6
npj Precision Oncology
48 papers in training set
Top 0.3%
2.8%
7
Computational and Structural Biotechnology Journal
216 papers in training set
Top 3%
2.4%
8
BMC Bioinformatics
383 papers in training set
Top 4%
2.1%
9
Life
27 papers in training set
Top 0.1%
1.7%
10
Frontiers in Oncology
95 papers in training set
Top 2%
1.7%
11
Bioinformatics
1061 papers in training set
Top 7%
1.7%
12
Molecular Oncology
50 papers in training set
Top 0.6%
1.3%
13
JNCI Cancer Spectrum
10 papers in training set
Top 0.3%
1.3%
14
BMC Medical Informatics and Decision Making
39 papers in training set
Top 2%
1.1%
15
Translational Oncology
18 papers in training set
Top 0.2%
1.0%
16
BMC Cancer
52 papers in training set
Top 2%
0.8%
17
Journal of Clinical Medicine
91 papers in training set
Top 6%
0.8%
18
Journal of Translational Medicine
46 papers in training set
Top 2%
0.8%
19
Biology Methods and Protocols
53 papers in training set
Top 2%
0.8%
20
Cancer Research Communications
46 papers in training set
Top 1%
0.7%
21
Journal of Medical Internet Research
85 papers in training set
Top 5%
0.5%
22
The Journal of Pathology
22 papers in training set
Top 0.7%
0.5%
23
Frontiers in Bioinformatics
45 papers in training set
Top 1%
0.5%
24
Biomedicines
66 papers in training set
Top 4%
0.5%
25
Cancer Research
116 papers in training set
Top 4%
0.5%
26
Modern Pathology
21 papers in training set
Top 0.6%
0.5%
27
Molecular & Cellular Proteomics
158 papers in training set
Top 2%
0.5%